ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
InMed Pharmaceuticals Inc

InMed Pharmaceuticals Inc (INM)

4,59
-0,07
(-1,50%)
Beim Schlusskurs: 27 Dezember 10:00PM
4,59
0,00
( 0,00% )
Nach Börsenschluss: 12:26AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
4,59
Gebot
4,40
Fragen
5,40
Volumen
8.680
4,57 Tagesbereich 4,73
2,414 52-Wochen-Bereich 15,576
Marktkapitalisierung
Handelsende
4,66
Handelsbeginn
4,66
Letzte Trade
1
@
5.47
Letzter Handelszeitpunkt
23:53:55
Finanzvolumen
US$ 40.149
VWAP
4,6254
Durchschnittliches Volumen (3 Mio.)
467.776
Ausgegebene Aktien
667.672
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,40
Gewinn pro Aktie (EPS)
-11,5
Erlöse
4,6M
Nettogewinn
-7,68M

Über InMed Pharmaceuticals Inc

InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, derm... InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Security Systems Service
Hauptsitz
Vancouver, British Columbia, Can
Gegründet
2014
InMed Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker INM. The last closing price for InMed Pharmaceuticals was US$4,66. Over the last year, InMed Pharmaceuticals shares have traded in a share price range of US$ 2,414 to US$ 15,576.

InMed Pharmaceuticals currently has 667.672 shares in issue. The market capitalisation of InMed Pharmaceuticals is US$3,11 million. InMed Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.40.

INM Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0924.54.84.14219394.41238188CS
40.296.744186046514.36.44.14268824.99990837CS
120.266.004618937644.337.163.654677765.7217526CS
26-0.474-9.360189573465.06415.5762.41436848357.81842705CS
52-2.79-37.80487804887.3815.5762.41421063857.62274724CS
156-25.41-84.7303902.414116226832.75459657CS
260-69.41-93.7972972973743902.414106068834.75963114CS

INM - Frequently Asked Questions (FAQ)

What is the current InMed Pharmaceuticals share price?
The current share price of InMed Pharmaceuticals is US$ 4,59
How many InMed Pharmaceuticals shares are in issue?
InMed Pharmaceuticals has 667.672 shares in issue
What is the market cap of InMed Pharmaceuticals?
The market capitalisation of InMed Pharmaceuticals is USD 3,11M
What is the 1 year trading range for InMed Pharmaceuticals share price?
InMed Pharmaceuticals has traded in the range of US$ 2,414 to US$ 15,576 during the past year
What is the PE ratio of InMed Pharmaceuticals?
The price to earnings ratio of InMed Pharmaceuticals is -0,4
What is the cash to sales ratio of InMed Pharmaceuticals?
The cash to sales ratio of InMed Pharmaceuticals is 0,67
What is the reporting currency for InMed Pharmaceuticals?
InMed Pharmaceuticals reports financial results in USD
What is the latest annual turnover for InMed Pharmaceuticals?
The latest annual turnover of InMed Pharmaceuticals is USD 4,6M
What is the latest annual profit for InMed Pharmaceuticals?
The latest annual profit of InMed Pharmaceuticals is USD -7,68M
What is the registered address of InMed Pharmaceuticals?
The registered address for InMed Pharmaceuticals is 340 - 200 GRANVILLE STREET, VANCOUVER, BRITISH COLUMBIA, V6C 1S4
What is the InMed Pharmaceuticals website address?
The website address for InMed Pharmaceuticals is www.inmedpharma.com
Which industry sector does InMed Pharmaceuticals operate in?
InMed Pharmaceuticals operates in the SECURITY SYSTEMS SERVICE sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TOIIWOncology Institute Inc
US$ 0,0197
(109,57%)
42,81k
EVAXEvaxion Biotech AS
US$ 1,5807
(86,84%)
6,97M
RVSNRail Vision Ltd
US$ 1,27
(64,17%)
6,65M
INTZIntrusion Inc
US$ 0,68
(51,11%)
3,24M
JSPRWJasper Therapeutics Inc
US$ 0,25
(47,06%)
343
MITAColiseum Acquisition Corporation
US$ 9,00
(-21,81%)
11,88k
VIRXViracta Therapeutics Inc
US$ 0,1896
(-20,00%)
404,16k
BDRXBiodexa Pharmaceuticals PLC
US$ 4,04
(-14,04%)
4,42k
SLGLSol Gel Technologies Ltd
US$ 1,07
(-12,30%)
32,99k
SPRCSciSparc Ltd
US$ 0,4401
(-11,98%)
1,7M
CRKNCrown Electrokinetics Corporation
US$ 0,1576
(19,67%)
35,77M
OMEXOdyssey Marine Exploration Inc
US$ 0,6449
(34,21%)
9,66M
QSIQuantum Si Inc
US$ 2,45
(13,95%)
8,06M
XTIAXTI Aerospace Inc
US$ 0,04
(0,00%)
7,63M
EVAXEvaxion Biotech AS
US$ 1,5807
(86,84%)
6,97M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock